COMPANY NAME |
REVENUES 12 Months Ending Q4 2024 |
MARKET SHARE 12 Months Q4 2024 |
MARKET SHARE MRQ Q4 2024 |
MARKET SHARE A Quarter Before Q3 2024 |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
12.26% |
12.30% |
11.89% |
Merck and Co Inc |
63,922.00 |
8.77% |
8.72% |
8.25% |
Pfizer Inc |
62,463.00 |
8.57% |
7.71% |
9.38% |
Abbvie Inc |
57,367.00 |
7.87% |
7.50% |
7.97% |
Sanofi |
49,599.72 |
6.81% |
6.81% |
0.00% |
Eli Lilly And Company |
49,003.20 |
6.73% |
7.15% |
7.14% |
Bristol myers Squibb Company |
47,636.00 |
6.54% |
6.29% |
6.52% |
Novartis Ag |
46,660.00 |
6.40% |
6.40% |
0.00% |
Astrazeneca Plc |
45,811.00 |
6.29% |
6.29% |
0.00% |
Abbott Laboratories |
42,344.00 |
5.81% |
5.82% |
5.79% |
Amgen Inc |
33,424.00 |
4.59% |
5.10% |
4.49% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.00% |
4.00% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
3.94% |
3.75% |
4.00% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
2.28% |
2.19% |
2.23% |
Viatris Inc |
14,330.20 |
1.97% |
1.83% |
1.86% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
1.93% |
1.70% |
2.00% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.52% |
1.56% |
1.54% |
Organon and Co |
6,294.00 |
0.86% |
0.85% |
0.84% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.56% |
0.50% |
0.57% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.50% |
0.53% |
0.44% |
United Therapeutics Corporation |
2,994.10 |
0.41% |
0.45% |
0.39% |
Royalty Pharma Plc |
2,263.85 |
0.31% |
0.32% |
0.31% |
Apellis Pharmaceuticals Inc |
775.84 |
0.11% |
0.09% |
0.11% |
Opko Health Inc |
689.41 |
0.09% |
0.08% |
0.10% |
Arvinas Inc |
426.90 |
0.06% |
0.11% |
0.03% |
Innoviva Inc |
408.35 |
0.06% |
0.05% |
0.05% |
Mirum Pharmaceuticals Inc |
379.25 |
0.05% |
0.06% |
0.05% |
Myovant Sciences Ltd |
379.11 |
0.05% |
0.06% |
0.06% |
Madrigal Pharmaceuticals Inc |
317.38 |
0.04% |
0.08% |
0.05% |
Mannkind Corporation |
297.60 |
0.04% |
0.04% |
0.04% |
Intercept Pharmaceuticals inc |
288.25 |
0.04% |
0.05% |
0.04% |
Legend Biotech Corporation |
285.14 |
0.04% |
0.04% |
0.00% |
Galapagos Nv |
268.49 |
0.04% |
0.04% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Aurinia Pharmaceuticals Inc |
247.30 |
0.03% |
0.04% |
0.03% |
Puma Biotechnology Inc |
232.71 |
0.03% |
0.03% |
0.03% |
Protagonist Therapeutics inc |
207.80 |
0.03% |
0.02% |
0.09% |
Ligand Pharmaceuticals Incorporated |
181.29 |
0.02% |
0.03% |
0.02% |
Fibrogen Inc |
180.01 |
0.02% |
0.00% |
0.00% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.01% |
Xencor Inc |
127.23 |
0.02% |
0.02% |
0.03% |
Siga Technologies Inc |
120.33 |
0.02% |
0.00% |
0.04% |
Anaptysbio inc |
111.87 |
0.02% |
0.02% |
0.02% |
Spectrum Pharmaceuticals Inc |
109.33 |
0.02% |
0.01% |
0.01% |
Y mabs Therapeutics inc |
88.66 |
0.01% |
0.01% |
0.01% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Theratechnologies Inc |
81.76 |
0.01% |
0.01% |
0.00% |
Theravance Biopharma inc |
65.27 |
0.01% |
0.01% |
0.01% |
Enanta Pharmaceuticals Inc |
64.46 |
0.01% |
0.01% |
0.01% |
Fortress Biotech Inc |
57.78 |
0.01% |
0.01% |
0.01% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Nurix Therapeutics Inc |
56.42 |
0.01% |
0.01% |
0.01% |
Journey Medical Corp |
56.24 |
0.01% |
0.01% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
2seventy Bio Inc |
48.37 |
0.01% |
0.01% |
0.00% |
Spero Therapeutics Inc |
44.58 |
0.01% |
0.00% |
0.01% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Mereo Biopharma Group Plc |
36.46 |
0.01% |
0.00% |
0.00% |
Chimerix Inc |
33.06 |
0.00% |
0.00% |
0.00% |
Assembly Biosciences Inc |
32.15 |
0.00% |
0.01% |
0.00% |
Lexicon Pharmaceuticals Inc |
31.21 |
0.00% |
0.00% |
0.01% |
Elicio Therapeutics Inc |
29.70 |
0.00% |
0.00% |
0.00% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Carisma Therapeutics Inc |
19.96 |
0.00% |
0.00% |
0.00% |
Aclaris Therapeutics Inc |
17.78 |
0.00% |
0.00% |
0.00% |
Veru Inc |
16.85 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Aptevo Therapeutics Inc |
12.99 |
0.00% |
0.00% |
0.00% |
Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
Nuvation Bio Inc |
10.79 |
0.00% |
0.00% |
0.00% |
Hookipa Pharma inc |
9.35 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Affimed N v |
9.27 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Pulmatrix Inc |
7.81 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Arbutus Biopharma Corp |
6.40 |
0.00% |
0.00% |
0.00% |
Qualigen Therapeutics Inc |
4.79 |
0.00% |
0.00% |
0.00% |
Matinas Biopharma Holdings Inc |
4.28 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
I mab |
3.89 |
0.00% |
0.00% |
0.00% |
Ayala Pharmaceuticals Inc |
3.74 |
0.00% |
0.00% |
0.00% |
Bolt Biotherapeutics Inc |
3.64 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Rapt Therapeutics Inc |
3.25 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
Galmed Pharmaceuticals Ltd |
2.04 |
0.00% |
0.00% |
0.00% |
Cocrystal Pharma Inc |
2.01 |
0.00% |
0.00% |
0.00% |
Humanigen Inc |
1.70 |
0.00% |
0.00% |
0.00% |
Corbus Pharmaceuticals Holdings Inc |
1.54 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Bellicum Pharmaceuticals Inc |
1.48 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Imunon Inc |
0.50 |
0.00% |
0.00% |
0.00% |
Applied Therapeutics Inc |
0.46 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Actavia Life Sciences Inc |
0.12 |
0.00% |
0.00% |
0.00% |
Adagene Inc |
0.10 |
0.00% |
0.00% |
0.00% |
Sangui Biotech International Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Regenerx Biopharmaceuticals inc |
0.08 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Cormedix Inc |
0.07 |
0.00% |
0.02% |
0.01% |
Serina Therapeutics Inc |
0.06 |
0.00% |
0.00% |
0.00% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
9 Meters Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Zyversa Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.01% |
Unicycive Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moleculin Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Apexigen Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tyme Technologies Inc. |
0.00 |
0.00% |
0.00% |
0.00% |
Rezolute Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pyxis Oncology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Allakos Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kezar Life Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
89bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nkarta Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.63% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Savara Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Gt Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atreca inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cytodyn inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pardes Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Corvus Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Bullfrog Ai Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Landos Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acurx Pharmaceuticals inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tempest Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Briacell Therapeutics Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Genelux Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Disc Medicine Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
728,584.63 |
100% |
177,998.75 |
100% |
CASI's Market share relative to its competitors, as of Q4 2024 within the Major Pharmaceutical Preparations Industry
CASI's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Casi Pharmaceuticals inc's market divisions, geographic dispersion, segments, products, and services, visit
Casi Pharmaceuticals inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.